You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Orphan Drugs in Oncology
Regulatory and Economic Aspects in Oncology
Springer, Cham, January 2019
Daria Korchagina, Szymon Jaroslawski, Guy Jadot, Mondher Toumi, Korchagina, Daria, Jaroslawski, Szymon, Jadot, Guy, Toumi, Mondher
The data shown below were collected from the profiles of 3 tweeters who shared this research output. Click here to find out more about how the information was compiled.
|Members of the public||2||67%|
|Practitioners (doctors, other healthcare professionals)||1||33%|
The data shown below were compiled from readership statistics for 23 Mendeley readers of this research output. Click here to see the associated Mendeley record.
|Readers by professional status||Count||As %|
|Student > Master||6||26%|
|Student > Doctoral Student||3||13%|
|Student > Bachelor||2||9%|
|Student > Ph. D. Student||2||9%|
|Readers by discipline||Count||As %|
|Pharmacology, Toxicology and Pharmaceutical Science||7||30%|
|Medicine and Dentistry||3||13%|
|Economics, Econometrics and Finance||2||9%|